Overview


Cell cryopreservation is a laboratory technique used to preserve living cells by cooling them to very low temperatures (typically −80 °C to −196 °C using liquid nitrogen) to halt all biological activity. This process protects cells from damage by using cryoprotective agents that prevent ice crystal formation. Cryopreserved cells can later be thawed and used for research, biobanking, drug development, and clinical applications such as regenerative medicine.

According to FutureWise analysis, the cell cryopreservation market in 2026 is US$5.37 billion and is expected to reach US$13.96 billion by 2036 at a CAGR of 10.02%. The significant growth of the cell cryopreservation market is being driven by an increasing demand for cell-based therapies, stem cell banking, and regenerative medicine. The expansion of the market can be attributed to a growing demand for stem cell therapies, regenerative medicine, and biobanking. Increased investments in research and development are playing a critical role, along with notable advancements in cryopreservation technologies that support market growth. Furthermore, the rise of cell-based therapeutics and personalized medicine is presenting substantial opportunities for stakeholders in the market on a global scale.

Growth Drivers

  • Increased demand for stem cell therapies and regenerative medicine necessitates long-term storage of viable cells.
  • Rising infertility rates have led to more procedures for fertility preservation, including the freezing of eggs, sperm, and embryos.
  • The expansion of biobanks and biorepositories is essential for supporting genomic research, drug discovery, and personalized medicine.
  • The increasing prevalence of chronic diseases is driving the demand for advanced cell-based therapies.
  • There has been an increase in investment in research and development (R&D) focused on biotechnology, as well as in clinical trials for cell and gene therapies.

Key Trends

  • The expansion of cell and gene therapy pipelines requires reliable solutions for cryopreservation.
  • The development of advanced cryoprotectants, serum-free media, and automated storage systems aims to enhance cell viability.
  • There is a growing adoption of biobanking and large-scale sample storage initiatives around the world.
  • The global popularity of fertility preservation and elective egg freezing is on the rise.
  • There is a growing trend toward personalized medicine and the development of cell-based drugs, which is increasing the demand for preserved biological samples.

Market Segmentation and Key Players

The cell cryopreservation market is segmented based on product type, application, end user, and region. By product type, the market includes cryoprotectant agents such as glycerol, dimethyl sulfoxide (DMSO), and others, along with equipment like freezers, incubators, and liquid nitrogen storage systems. Based on application, it covers stem cells, oocytes and embryos, sperm/semen and testicular tissues, hepatocytes, and other cell types used in research and clinical practices. In terms of end users, the market serves pharmaceutical and biotechnology companies, academic and research institutes, biobanks, and other healthcare organizations. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. For a complete breakdown, refer to the segmentation section below.

Key players operating in this market include Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Corning Incorporated, BioLife Solutions Inc., and others.

Research Methodology

The research methodology for the cell cryopreservation market combines both primary and secondary research. Secondary research involves gathering data from industry reports, company publications, scientific journals, government databases, and reputable market research sources to identify market trends and segmentation. 

Primary research consists of conducting interviews and discussions with industry experts, key opinion leaders, manufacturers, and distributors to validate the collected data. The information obtained is then analyzed using market modeling, data triangulation, and forecasting techniques to estimate market size, growth trends, and the competitive landscape.

  • General Electric Company
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • AMS Biotechnology Limited
  • Miltenyi Biotec GmbH
  • BioLifeSolutions Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • PromoCell GmbH
  • Corning Incorporated
  • Cooper Companies, Inc.
  • Planer PLC

(Note: The list of major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Cell Cryopreservation Market:

BioLifeSolutions Inc.

  • In April 2025, BioLife acquired PanTHERA CryoSolutions, which added proprietary Ice Recrystallization Inhibitor (IRI) technology and enhanced its cell preservation offerings.
  • As of the first quarter of 2025, BioLife processed 13 new FDA Master File cross-references, integrating their biopreservation media into 17 commercial cell and gene therapies, with further expansion anticipated shortly.

Thermo Fisher Scientific Inc.

  • Launched the TSV series of ULT freezers in August 2023 (Made in India), offering enhanced temperature uniformity and stability—ideal for long-term cell storage and viability preservation
  • The company is expanding its pharma services footprint in 2025, including building an additional 5,000?L and 2,000?L bioreactors at key sites (St. Louis and Switzerland), enhancing biologics manufacturing capacity relevant for cell-therapy supply chains

Merck KGaA

  • Offers a comprehensive line of CryoStor® cryopreservation media, including serum-free formulations designed for diverse cell types such as stem cells and CAR-T therapies. These media emphasize regulatory compliance and performance consistency in clinical-grade cell storage.
  • In 2024, Merck made a significant investment (~USD 322 million) in a Bioprocessing Production Center in Daejeon, South Korea—Merck’s largest Life Science investment in Asia-Pacific—boosting its capacity to support cell therapy manufacturing and cryopreservation supply needs through 2028

Miltenyi Biotec GmbH

  • Opened its first India office in Hyderabad in early 2024 and is investing in a Cell & Gene Therapy Center of Excellence, offering hands-on training and clinical research support using Miltenyi tools like CliniMACS Prodigy which supports automated, closed-system cell processing and cryopreservation workflows

In May 2022, Bristol Myers Squibb, a global biopharmaceutical company, announced that Breyanzi has been authorised by the European Commission for individuals with primary mediastinal large B-cell lymphoma (PMBCL) and relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).

The field of cell cryopreservation has garnered substantial interest in recent years due to its ability to facilitate the long-term storage and preservation of valuable biological materials, including stem cells, tissues, and organs. The global cell cryopreservation market has seen significant advancement in recent years, and one of the main drivers of the market is the increasing demand for cell-based therapies and regenerative medicine. These therapies rely on the availability of viable and functional cells, which can be cryopreserved and stored for future use. As such, there has been a growing need for efficient and reliable cryopreservation techniques that can ensure the long-term viability of these cells. The cell cryopreservation market is also driven by the increasing awareness and adoption of personalized medicine. With the ability to cryopreserve and store a patient's own cells, personalized medicine can provide a more targeted and effective approach to disease treatment. This has led to an increasing demand for cryopreservation services and facilities that can cater to the needs of individual patients.

However, the high cost of cryopreservation can be a barrier to adoption for many patients and healthcare providers. In addition, there is a demand for further research and development to optimize cryopreservation techniques and improve the long-term viability of stored cells. Overall, the global cell cryopreservation market is anticipated to grow in the years to come.

By Product Type

  • Cryoprotectant Agents
    •  Glycerol
    •  Dimethyl Sulfoxide (DMSO)
    •  Others
  • Equipment
    •  Incubators
    •  Liquid Nitrogen Supply Tanks
    •  Freezers
    •  Others

By Application

  • Stem Cells
  • Oocytes and Embryos
  • Sperm, Semen, and Testicular Tissue
  • Hepatocytes
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Biobank
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

North America

  • High concentration of key players: The U.S. hosts significant biotech and pharmaceutical companies investing in stem cell therapies, regenerative medicine, and biobanking.
  • Robust R&D infrastructure: Leading research institutions, hospitals, and biotechnology centers are at the forefront of developing innovative techniques and technologies in cryopreservation.
  • Favorable regulatory environment: Policies and frameworks in the U.S. and Canada support the development of cell-based therapeutics and storage solutions.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. North America is likely to dominate the cell cryopreservation market during the forecast period. This is a result of the region's rising healthcare spending on R&D by pharmaceutical and biotech firms, which is expected to have a substantial influence on the industry in the years to come. The presence of a well-established healthcare infrastructure, increased investments in regenerative medicine and cell-based treatments, and the growing incidence of chronic illnesses are some of the factors influencing the expansion of the cell cryopreservation market in North America. Additionally, the biotech and pharmaceutical businesses in this region are investing extensively in R&D operations to create new and novel medications and treatments for various ailments, fuelling the need for cell cryopreservation


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cell Cryopreservation Market By Product Type, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cell Cryopreservation Market Variables, Trends and Scope
    •      1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cell Cryopreservation Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cell Cryopreservation Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cell Cryopreservation Market, By Product Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Cryoprotectant Agents
         1.1. Glycerol
         1.2. Dimethyl Sulfoxide (DMSO)
         1.3. Others
        2. Equipment
         2.1. Incubators
         2.2. Liquid Nitrogen Supply Tanks
         2.3. Freezers
         2.4. Others

  • 8.   Cell Cryopreservation Market, By Application Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Stem Cells
        2. Oocytes and Embryos
        3. Sperm, Semen, and Testicular Tissue
        4. Hepatocytes
        5. Others

  • 9.   Cell Cryopreservation Market, By End User Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Pharmaceutical and Biotechnology Companies
        2. Academic and Research Institutes
        3. Biobank
        4. Others

  • 10.   North America Cell Cryopreservation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 11.   Latin America Cell Cryopreservation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 12.   Europe Cell Cryopreservation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 13.   Asia Pacific Cell Cryopreservation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 14.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. General Electric Company
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck KGaA
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. AMS Biotechnology Limited
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Miltenyi Biotec GmbH
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. BioLifeSolutions Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. HiMedia Laboratories Pvt. Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. PromoCell GmbH
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Corning Incorporated
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cooper Companies, Inc.
         10.1. Company Overview
         10.2. Disease Type Portfolio
         10.3. Financial Overview
         10.4. Key Highlights
         10.5. Market Strategies
        11. Planer PLC
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

FAQ


The market scope typically includes cryopreservation storage systems, cryoprotective agents, cell cryopreservation media, equipment, services, and related technologies. It covers different cell types such as stem cells, immune cells, and reproductive cells, among others.

A wide variety of cell types can be cryopreserved, including sperm, eggs, embryos, stem cells, cancer cells, and various other types of primary and cultured cells used in research and medical treatments.

Innovations include the development of new cryoprotectants, automated cryopreservation systems, and improved thawing equipment. Trends also include an increased focus on personalized medicine and advanced therapy medicinal products (ATMPs).

The growth of the cell cryopreservation market is driven by numerous factors including the rising demand for regenerative medicines, advancements in biobanking, and growing research in cell-based therapies.

The benefits of the Cell Cryopreservation Market include:
Extended Preservation: Enables long-term storage of biological samples without significant loss of viability.
Enhanced Research: Facilitates complex research by allowing cells to be stored and used when needed.
Advancement in Therapies: Cryopreservation is critical for advancements in regenerative medicine, including organ transplantation and stem cell therapies.

Related Market

Cryopreservation Equipment Market

Read More

Biobanking Market

Read More

Biopreservation Market

Read More

Tissue Banking Market

Read More

Cell Culture Market

Read More

Blood Cell Washers Kits Market

Read More
Partner

Our Clients